Can Hyperbaric Oxygen Therapy Help With Chronic Pain? What the Research Says

Chronic pain is a pervasive and complex medical challenge that affects millions of individuals worldwide, often persisting long after the initial injury has healed. Unlike acute pain, which serves as a vital warning signal of tissue damage, chronic pain is often considered a disease in its own right – a state where the nervous system remains in a persistent high-alert mode. Traditional management strategies, including non-steroidal anti-inflammatory drugs (NSAIDs) and opioids, frequently focus on masking the symptoms rather than addressing the underlying biological malfunctions.

However, Hyperbaric Oxygen Therapy (HBOT) is gaining significant recognition in clinical research as a sophisticated, non-pharmacological intervention for various pain syndromes: this therapy works by delivering pure oxygen – at pressures greater than sea-level atmospheric pressure – to address the fundamental drivers of pain: inflammation, tissue hypoxia, and neurological dysregulation. 

The Biological Foundation: How Oxygen Influences Pain

The human body’s ability to repair itself is entirely dependent on the availability of oxygen. Oxygen is the primary fuel for mitochondrial ATP production, which provides the energy necessary for every cellular repair process. In many chronic pain conditions, tissues enter a state of “hypoxia,” where the demand for oxygen exceeds the supply. This lack of oxygen triggers the release of distress signals, such as Substance P and lactic acid, which irritate nerve endings and sustain the perception of pain.

Under normal conditions, oxygen is carried through the body almost exclusively by red blood cells. However, in a hyperbaric environment, the increased atmospheric pressure forces oxygen to dissolve directly into the blood plasma. This is governed by Henry’s Law, which states that a gas will dissolve into a liquid in proportion to the pressure exerted upon it. This oxygen-saturated plasma can reach areas where circulation is compromised, effectively paying off the “oxygen debt” in the tissues and allowing the metabolic processes of healing to resume.

Mechanism 1: Reducing Pro-Inflammatory Cytokines

Chronic pain and chronic inflammation are inextricably linked. When tissues are under stress, the immune system releases pro-inflammatory cytokines such as Tumor Necrosis Factor-alpha (TNF-α) and various Interleukins (IL-1, IL-6). These chemicals act as irritants to the peripheral nerves, lowering the threshold required to trigger a pain signal. Research indicates that HBOT has a profound impact on these chemical messengers.

Clinical studies have demonstrated that hyperbaric oxygen therapy can significantly down-regulate the expression of pro-inflammatory genes while simultaneously up-regulating anti-inflammatory signals like IL-10. This biochemical shift helps “cool down” the inflammatory environment surrounding the nerves. By reducing the systemic inflammatory load, HBOT provides a structural solution to pain that is often more durable than the temporary relief provided by anti-inflammatory medications.

Mechanism 2: Inhibiting Glial Cell Activation and Neuroinflammation

In recent years, the medical community has recognized that chronic pain is often maintained by the “support cells” of the central nervous system, known as glial cells. When these cells become over-activated – a process called gliosis – they release neuroinflammatory substances that keep the spinal cord and brain in a state of “central sensitization.” This means the nervous system becomes excessively sensitive, perceiving even minor stimuli as intense pain.

HBOT is one of the few interventions capable of crossing the blood-brain barrier to directly influence these cells. Research shows that hyperbaric oxygen inhibits the activation of microglia and astrocytes. By “calming” these cells, the therapy helps reset the brain’s pain-processing centers. This is particularly relevant for complex conditions such as Fibromyalgia and Complex Regional Pain Syndrome (CRPS), where the pain is driven more by the nervous system’s sensitivity than by an ongoing physical injury.

Mechanism 3: Stimulating Angiogenesis and Tissue Perfusion

A major cause of chronic pain, particularly in conditions like diabetic neuropathy or peripheral vascular disease, is ischemia – inadequate blood supply to the tissues. Ischemic tissues are highly painful because they lack the oxygen needed to function and are unable to flush out metabolic waste. HBOT addresses this by promoting “angiogenesis,” the formation of new micro-vessels.

The temporary state of high-pressure oxygen followed by a return to normal pressure triggers the release of Vascular Endothelial Growth Factor (VEGF). This signal tells the body to build new blood vessel networks in oxygen-starved areas. As these new vessels develop, the tissue receives a permanent increase in blood flow and oxygenation. This mechanical improvement in tissue perfusion provides a long-term foundation for pain relief, as the tissues are finally able to “breathe” and repair themselves.

Mechanism 4: Activating Endogenous Opioid Pathways

The human body possesses an internal “pharmacy” capable of producing its own pain-relieving chemicals, known as endorphins and enkephalins. These endogenous opioids bind to the same receptors in the brain as pharmaceutical painkillers but without the associated risks of addiction, respiratory depression, or constipation.

Evidence suggests that HBOT can stimulate the release of these natural opioids. This is likely due to the therapy’s effect on the hypothalamus and the pituitary gland, which regulate the body’s hormonal and chemical responses to stress. Many patients report an immediate sense of well-being and a significant reduction in pain intensity following a session, a phenomenon often attributed to this natural analgesic surge.

Mechanism 5: Enhancing Nerve Regeneration

For patients suffering from neuropathic pain – characterized by burning, tingling, or “electric shock” sensations – the primary goal is nerve repair. Nerve cells are among the most energy-hungry cells in the body, and their regeneration requires a constant and abundant supply of oxygen. HBOT provides the “metabolic fuel” required for Schwann cells to repair the myelin sheath and for axons to grow back after injury.

By increasing the availability of dissolved oxygen in the cerebrospinal fluid, HBOT supports the energy-intensive process of neural repair. Research has shown that hyperbaric environments can increase the mobilization of stem cells, which then migrate to the sites of nerve damage to assist in the regenerative process. This neuroprotective and neuro-regenerative effect is vital for reversing the damage associated with chronic nerve compression and peripheral neuropathies.

Mechanism 6: Resolving Oxidative Stress and Mitochondrial Fatigue

At the cellular level, chronic pain is often a symptom of mitochondrial distress. When cells are unable to produce energy efficiently, they create excessive reactive oxygen species (ROS), leading to oxidative stress. This stress damages cellular components and maintains the pain signal. While it might seem counterintuitive to add more oxygen, HBOT actually triggers a “hormetic” response that strengthens the body’s antioxidant defenses.

The controlled exposure to hyperbaric oxygen signals the body to produce more of its own internal antioxidants, such as superoxide dismutase (SOD) and glutathione. This helps neutralize the free radicals that contribute to pain and tissue damage. Furthermore, the increased oxygen supply allows mitochondria to shift into a more efficient mode of energy production, reducing the metabolic “noise” that the brain perceives as chronic discomfort.

Clinical Evidence for Specific Pain Conditions

Research into HBOT has covered a wide range of chronic pain syndromes, providing evidence for its efficacy across various medical disciplines.

• Fibromyalgia: A landmark study published in PLOS ONE demonstrated that a course of 40 HBOT sessions could significantly reduce pain and improve quality of life for fibromyalgia patients. Brain imaging in the study showed that the therapy helped normalize activity in the pain-processing regions of the brain.
• Complex Regional Pain Syndrome (CRPS): Studies indicate that HBOT can reduce the edema, redness, and intense pain associated with CRPS by improving microcirculation and calming neuroinflammation.
• Migraines and Cluster Headaches: By causing cerebral vasoconstriction (which reduces the “throbbing” of vessels) while simultaneously increasing oxygen delivery to the brain tissue, HBOT has been used to abort acute attacks and reduce the frequency of chronic headaches.
• Myofascial Pain Syndrome: By resolving the localized hypoxia in “trigger points,” HBOT helps relax chronically tight muscles and clear the lactic acid buildup that contributes to persistent muscular aches.

FAQs

How many sessions of HBOT are needed for chronic pain?

For chronic conditions involving neuroinflammation or tissue repair, clinical evidence suggests a protocol of 20 to 40 sessions. This duration is necessary to facilitate the structural changes, such as new blood vessel growth and nerve regeneration, required for lasting relief.

Is the pain relief from HBOT immediate?

Many patients experience an acute reduction in pain after just a few sessions due to the anti-inflammatory and opioid-stimulating effects. However, the goal of a full protocol is to achieve long-term physiological changes that remain after the sessions are completed.

Does HBOT work for pain from old injuries?

Yes. HBOT is effective for “old” pain because it can address persistent neuroinflammation and localized hypoxia that may have remained in the tissue for years. It helps the body complete the healing processes that were stalled by a lack of oxygen.

Is it safe to use a hyperbaric chamber while taking pain medication?

HBOT is a non-pharmacological therapy and generally does not interact with pain medications. In many cases, patients find they can work with their doctors to gradually reduce their medication dosages as their symptoms improve through oxygen therapy.

Can HBOT help with the emotional toll of chronic pain?

Yes. By reducing neuroinflammation in the limbic system (the brain’s emotional center) and improving sleep quality, HBOT can help alleviate the anxiety and depression that often accompany chronic pain.

Are there side effects to consider?

The most common side effect is ear pressure during the compression phase, similar to flying in an airplane. In rare cases, frequent sessions can cause temporary changes in vision (nearsightedness), which usually resolves after the treatment course ends.

Final Thoughts

The mounting body of evidence supporting Hyperbaric Oxygen Therapy for chronic pain signals a shift toward more biological and restorative pain management. By addressing the root causes of discomfort – specifically the trio of hypoxia, inflammation, and nervous system sensitization – HBOT provides a comprehensive alternative to the “masking” approach of traditional pharmaceuticals. Through the laws of physics, we can deliver life-sustaining oxygen to the deepest recesses of the body, allowing for the regeneration of nerves, the growth of new blood vessels, and the quieting of an overactive brain. As we continue to refine our understanding of mitochondrial health and neuro-immunology, HBOT stands out as an essential, evidence-based tool for those looking to reclaim their lives from the burden of chronic pain.

Sources and Clinical References

• Efrati, S., et al. (2015). “Hyperbaric Oxygen Therapy Can Diminish Fibromyalgia Syndrome – Prospective Clinical Trial.” PLOS ONE.
• Gu, N., et al. (2014). “Hyperbaric oxygen treatment produces an antinociceptive response phase and inhibits astrocyte activation.” Journal of Molecular Neuroscience.
• Bennett, M. H., et al. (2011). “Hyperbaric oxygen therapy for musculoskeletal pain.” Cochrane Database of Systematic Reviews.
• Harch, P. G. (2015). “The application of hyperbaric oxygen therapy to chronic stress-induced neurological conditions.” Journal of Neurotrauma.
• Yengil, E., et al. (2025). “Advancements in hyperbaric medicine for chronic pain management.” Journal of Clinical Medicine.